Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Dawson

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Nature Medicine|September 9, 2017
SPOP tips the balance of BETs in cancerKatie A Fennell, Mark A Dawson
Cancer Cell|January 10, 2018
TFIID and MYB Share a Therapeutic Handshake in AMLCharles C Bell, Mark A Dawson
Molecular Cell|June 20, 2020
Place Your BETs in Combination TherapyBrian J Liddicoat, Mark A Dawson
Science (New York, N.Y.)|May 28, 2026
Australia's erosion of peer reviewMark A Dawson, Massimo A Hilliard
Haematologica|January 19, 2007
Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chainsMark A Dawson, Sushrut Patil, Andrew Spencer
Briefings in Functional Genomics|April 2, 2013
Bromodomains as therapeutic targets in cancerIsaia Barbieri, Ester Cannizzaro, Mark A Dawson
Haematologica|December 5, 2014
Epigenetics in the hematologic malignanciesChun Yew Fong, Jessica Morison, Mark A Dawson
Blood|November 8, 2019
Epigenetic therapies in acute myeloid leukemia: where to from here?Katie A Fennell, Charles C Bell, Mark A Dawson
Experimental Hematology|September 22, 2020
The old and the new: DNA and RNA methylation in normal and malignant hematopoiesisAndrew A Guirguis, Brian J Liddicoat, Mark A Dawson
Nature Reviews. Cancer|October 9, 2020
Non-genetic mechanisms of therapeutic resistance in cancerJean-Christophe Marine, Sarah-Jane Dawson, Mark A Dawson
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Nature Medicine|September 9, 2017
SPOP tips the balance of BETs in cancerKatie A Fennell, Mark A Dawson
Cancer Cell|January 10, 2018
TFIID and MYB Share a Therapeutic Handshake in AMLCharles C Bell, Mark A Dawson
Molecular Cell|June 20, 2020
Place Your BETs in Combination TherapyBrian J Liddicoat, Mark A Dawson
Science (New York, N.Y.)|May 28, 2026
Australia's erosion of peer reviewMark A Dawson, Massimo A Hilliard
Haematologica|January 19, 2007
Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chainsMark A Dawson, Sushrut Patil, Andrew Spencer
Briefings in Functional Genomics|April 2, 2013
Bromodomains as therapeutic targets in cancerIsaia Barbieri, Ester Cannizzaro, Mark A Dawson
Haematologica|December 5, 2014
Epigenetics in the hematologic malignanciesChun Yew Fong, Jessica Morison, Mark A Dawson
Blood|November 8, 2019
Epigenetic therapies in acute myeloid leukemia: where to from here?Katie A Fennell, Charles C Bell, Mark A Dawson
Experimental Hematology|September 22, 2020
The old and the new: DNA and RNA methylation in normal and malignant hematopoiesisAndrew A Guirguis, Brian J Liddicoat, Mark A Dawson
Nature Reviews. Cancer|October 9, 2020
Non-genetic mechanisms of therapeutic resistance in cancerJean-Christophe Marine, Sarah-Jane Dawson, Mark A Dawson
Pageof 11